This company listing is no longer active
7UK0 Stock Overview
Babylon Holdings Limited operates as a digital healthcare company. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Babylon Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.49 |
| 52 Week High | US$22.50 |
| 52 Week Low | US$0.38 |
| Beta | 1.73 |
| 11 Month Change | 0% |
| 3 Month Change | -65.83% |
| 1 Year Change | -97.44% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7UK0 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | 3.0% | 0.8% |
| 1Y | -97.4% | -31.4% | 8.6% |
Return vs Industry: 7UK0 underperformed the German Healthcare Services industry which returned 9.6% over the past year.
Return vs Market: 7UK0 underperformed the German Market which returned 3.2% over the past year.
Price Volatility
| 7UK0 volatility | |
|---|---|
| 7UK0 Average Weekly Movement | 33.8% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7UK0's share price has been volatile over the past 3 months.
Volatility Over Time: 7UK0's weekly volatility has increased from 22% to 34% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 1,895 | Parsa Parsadoust | www.babylonhealth.com |
Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services.
Babylon Holdings Limited Fundamentals Summary
| 7UK0 fundamental statistics | |
|---|---|
| Market cap | €385.02k |
| Earnings (TTM) | -€232.83m |
| Revenue (TTM) | €1.05b |
0.0x
P/S Ratio0.0x
P/E RatioIs 7UK0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7UK0 income statement (TTM) | |
|---|---|
| Revenue | US$1.15b |
| Cost of Revenue | US$1.15b |
| Gross Profit | US$3.13m |
| Other Expenses | US$258.71m |
| Earnings | -US$255.58m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -9.98 |
| Gross Margin | 0.27% |
| Net Profit Margin | -22.14% |
| Debt/Equity Ratio | -93.8% |
How did 7UK0 perform over the long term?
See historical performance and comparison